Find Nitisinone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

131 RELATED EXCIPIENT COMPANIES

222EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 104206-65-7, Orfadin, 2-(2-nitro-4-(trifluoromethyl)benzoyl)cyclohexane-1,3-dione, Nitisone, Ntbc, 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
Molecular Formula
C14H10F3NO5
Molecular Weight
329.23  g/mol
InChI Key
OUBCNLGXQFSTLU-UHFFFAOYSA-N
FDA UNII
K5BN214699

Nitisinone
Nitisinone is a synthetic reversible inhibitor of 4-hydroxyphenylpyruvate dioxygenase. It is used in the treatment of hereditary tyrosinemia type 1. It is sold under the brand name Orfadin.
Nitisinone is a 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor. The mechanism of action of nitisinone is as a Hydroxyphenylpyruvate Dioxygenase Inhibitor, and Cytochrome P450 2C9 Inhibitor, and Cytochrome P450 2E1 Inducer, and Organic Anion Transporter 1 Inhibitor, and Organic Anion Transporter 3 Inhibitor.
1 2D Structure

Nitisinone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione
2.1.2 InChI
InChI=1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2
2.1.3 InChI Key
OUBCNLGXQFSTLU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
K5BN214699
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(2-nitro-4-(trifluoromethyl)benzoyl)cyclohexane-1,3-dione

2. 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione

3. Ntbc Cpd

4. Orfadin

2.3.2 Depositor-Supplied Synonyms

1. 104206-65-7

2. Orfadin

3. 2-(2-nitro-4-(trifluoromethyl)benzoyl)cyclohexane-1,3-dione

4. Nitisone

5. Ntbc

6. 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione

7. 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione

8. 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione

9. Sc 0735

10. Sc-0735

11. 2-(alpha,alpha,alpha-trifluoro-2-nitro-p-tuluoyl)-1,3-cyclohexanedione

12. 1,3-cyclohexanedione, 2-[2-nitro-4-(trifluoromethyl)benzoyl]-

13. 2-{[2-nitro-4-(trifluoromethyl)phenyl]carbonyl}cyclohexane-1,3-dione

14. Chembl1337

15. Chebi:50378

16. 1,3-cyclohexanedione, 2-(2-nitro-4-(trifluoromethyl)benzoyl)-

17. Mfcd01752192

18. Sc0735

19. K5bn214699

20. Nitisinone [inn]

21. Nitisinone [usan:inn]

22. Nitisinona

23. Nitisinonum

24. Smr002529592

25. Orfadin (tn)

26. Nitisinone (jan/usan/inn)

27. Unii-k5bn214699

28. Nityr

29. Fe-0200

30. 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione

31. Nitisinone [mi]

32. Nitisinone [jan]

33. Nitisinone [usan]

34. Nitisinone [vandf]

35. Nitisinone [mart.]

36. Nitisinone [who-dd]

37. Bidd:pxr0129

38. Mls004774025

39. Mls006011955

40. Nitisinone [ema Epar]

41. Schembl338795

42. Ambz0071

43. Gtpl6834

44. Dtxsid9042673

45. Nitisinone [orange Book]

46. Nitisinone, >=95% (hplc)

47. Schembl15996621

48. Hms3740a15

49. Hms3870k03

50. Bcp15276

51. Hy-b0607

52. Bdbm50088804

53. Nsc773149

54. Rb3134

55. S5325

56. Akos015891363

57. Akos015994590

58. Zinc100014475

59. Am62666

60. Ccg-222085

61. Db00348

62. Ex-6233

63. Nsc-773149

64. Sb19017

65. Ncgc00185778-01

66. Ncgc00185778-02

67. Ncgc00185778-04

68. Ncgc00185778-07

69. Ac-26934

70. Sy047291

71. Db-014936

72. Ft-0672739

73. D05177

74. A800922

75. Sr-01000940576

76. J-505680

77. Q3877355

78. Sr-01000940576-2

79. Ntbc; Nitisone; Sc0735; Sc 0735; Sc-0735

80. Z1514110653

81. 1,3-cyclohexanedione,2-[2-nitro-4-(trifluoromethyl)benzoyl]-

82. 2-(2-nitro-4-(trifluoromethyl)-benzoyl)cyclohexane-1,3-dione

83. 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione;nitisinone

84. 2-(.alpha.,.alpha.,.alpha.-trifluoro-2-nitro-p-tuluoyl)-1,3-cyclohexanedione

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 329.23 g/mol
Molecular Formula C14H10F3NO5
XLogP32.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count2
Exact Mass329.05110691 g/mol
Monoisotopic Mass329.05110691 g/mol
Topological Polar Surface Area97 Ų
Heavy Atom Count23
Formal Charge0
Complexity524
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameOrfadin
PubMed HealthNitisinone (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelOrfadin contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase inhibitor indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1 (HT-1). Nitisinone occurs as white to...
Active IngredientNitisinone
Dosage FormCapsule
RouteOral
Strength5mg; 2mg; 10mg
Market StatusPrescription
CompanySwedish Orphan

2 of 2  
Drug NameOrfadin
PubMed HealthNitisinone (By mouth)
Drug ClassesGastrointestinal Agent
Drug LabelOrfadin contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase inhibitor indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1 (HT-1). Nitisinone occurs as white to...
Active IngredientNitisinone
Dosage FormCapsule
RouteOral
Strength5mg; 2mg; 10mg
Market StatusPrescription
CompanySwedish Orphan

4.2 Drug Indication

Used as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1.


FDA Label


Hereditary tyrosinemia type 1 (HT 1)

Orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT 1) in combination with dietary restriction of tyrosine and phenylalanine.

Alkaptonuria (AKU)

Orfadin is indicated for the treatment of adult patients with alkaptonuria (AKU).


Treatment of adult and paediatric patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.


Treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT 1) in combination with dietary restriction of tyrosine and phenylalanine.


Treatment of tyrosinemia type 1


5 Pharmacology and Biochemistry
5.1 Pharmacology

Hereditary tyrosinemia type 1 occurs due to a deficiency in fumarylacetoacetase (FAH), the final enzyme in the tyrosine catabolic pathway. Nitisinone inhibits catabolism of tyrosine by preventing the catabolic intermediates. In patients with HT-1, these catabolic intermediates are converted to the toxic metabolites succinylacetone and succinylacetoacetate, which are responsible for the observed liver and kidney toxicity. Succinylacetone can also inhibit the porphyrin synthesis pathway leading to the accumulation of 5-aminolevulinate, a neurotoxin responsible for the porphyric crises characteristic of HT-1.


5.2 MeSH Pharmacological Classification

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
NITISINONE
5.3.2 FDA UNII
K5BN214699
5.3.3 Pharmacological Classes
Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 2E1 Inducers [MoA]; Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]; 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]
5.4 ATC Code

A16AX04


A16AX04


A16AX04


A - Alimentary tract and metabolism

A16 - Other alimentary tract and metabolism products

A16A - Other alimentary tract and metabolism products

A16AX - Various alimentary tract and metabolism products

A16AX04 - Nitisinone


5.5 Absorption, Distribution and Excretion

Absorption

The capsule and liquid formulations are bioequivalent in both the plasma concentration-time curve and maximum plasma concentration (Cmax).


5.6 Biological Half-Life

~54 hours


5.7 Mechanism of Action

Nitisinone is a competitive inhibitor of 4-hydroxyphenyl-pyruvate dioxygenase, an enzyme upstream of fumarylacetoacetate hydrolyase (FAH) in the tyrosine catabolic pathway. By inhibiting the normal catabolism of tyrosine in patients with hereditary tyrosinemia type 1 (HT-1), nitisinone prevents the accumulation of the catabolic intermediates maleylacetoacetate and fumarylacetoacetate.


API SUPPLIERS

read-more
read-more

01

Biophore India Pharmaceuticals Pvt...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Biophore

02

Nuray Chemicals Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
Nuray Chemicals

03

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down AUDIT
HRV Global Life Sciences

04

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Omgene Company Banner

05

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI offers customized CDMO Solutions for API development and manufacturing services.

Flag Israel
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

06

Saurav Chemicals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AES 2024
Not Confirmed
arrow

Saurav Chemicals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

07

Dipharma SA

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AES 2024
Not Confirmed
arrow

Dipharma SA

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AES 2024
Not Confirmed
arrow

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Sionc Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AES 2024
Not Confirmed
arrow

Sionc Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

10

Alven Laboratories

Czech Republic

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AES 2024
Not Confirmed
arrow

Alven Laboratories

Czech Republic

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AES 2024
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2020-08-28

Pay. Date : 2020-08-06

DMF Number : 33948

Submission : 2019-07-17

Status : Active

Type : II

Biophore

02

Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2017-02-01

Pay. Date : 2016-12-26

DMF Number : 31250

Submission : 2017-01-02

Status : Active

Type : II

Nuray Chemicals

03

Dipharma Sa

Switzerland

USDMF

arrow
Medlab Asia & Asia Health
Not Confirmed

03

Dipharma Sa

Switzerland
arrow
Medlab Asia & Asia Health
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-09-21

Pay. Date : 2021-08-02

DMF Number : 36026

Submission : 2021-07-31

Status : Active

Type : II

blank

04

Saurav Chemicals Ltd

India

USDMF

arrow
Medlab Asia & Asia Health
Not Confirmed

04

Medlab Asia & Asia Health
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35810

Submission : 2021-03-31

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

Nitisinone IH

Date of Issue : 2024-02-20

Valid Till : 2026-12-06

Written Confirmation Number : WC-0416

Address of the Firm : Plot No. 111 SIDCO Industrial Estate, Kakkalur Thiruvallur-602003 Tamil Nadu, In...

Nuray Chemicals

02

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

Nitisinone IH

Date of Issue : 2021-09-17

Valid Till : 2022-08-13

Written Confirmation Number : WC-0171Amendment

Address of the Firm : (Unit-III), Village-Bhagwanpur, Barwala Road, Derabassi, Dist-Mohali (Punjab)

blank

03

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

Nitisinone IH

Date of Issue : 2020-07-23

Valid Till : 2023-05-11

Written Confirmation Number : WC-0273

Address of the Firm : Plot No. 34A, J.N.Pharma City, Thanam (V), Parawada (M), Vishakhapatnam-District...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

Bachem AG

Switzerland
arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

NITISINONE

NDC Package Code : 55463-0034

Start Marketing Date : 2004-08-17

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Bachem company banner

02

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

NITISINONE

NDC Package Code : 58159-037

Start Marketing Date : 2020-02-05

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (35kg/35kg)

Marketing Category : BULK INGREDIENT

Nuray Chemicals

03

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

NITISINONE

NDC Package Code : 66005-0046

Start Marketing Date : 2015-09-10

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

NITISINONE

NDC Package Code : 76438-004

Start Marketing Date : 2019-06-18

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

05

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

NITISINONE

NDC Package Code : 43235-0016

Start Marketing Date : 2020-03-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

NITISINONE

NDC Package Code : 76055-0043

Start Marketing Date : 2019-07-24

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

NITISINONE

NDC Package Code : 68022-7058

Start Marketing Date : 2018-12-26

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Nitisinone

About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...

Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore

02

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

Nitisinone

About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...

Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in the Indian state of Tamil Nadu. Nuray’s expertise and experience lie in developing the chemistry requirements of the pharmaceutical industry, including the synthesis of NCEs, impurities, metabolites, method development, advanced intermediates and APIs for commercial launch. With its focus on maintaining the highest levels of quality, reliability and transparency, Nuray has emerged as a trusted partner in the global generic market.
Nuray Chemicals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Nitisinone

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

04

arrow
AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Nitisinone

About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically...

Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integrated company, we focus on developing high-quality formulations based on in-house-produced actives. With GMP-certified facilities and partnerships with contract manufacturers, we excel in formulation development for injectables, lyophilized injectables, complex generics, and oral peptide delivery systems, ensuring affordable, top-quality medicines.
Omgene Company Banner

05

Alven Laboratories

Czech Republic
AES 2024
Not Confirmed
arrow

Alven Laboratories

Czech Republic
arrow
AES 2024
Not Confirmed

Nitisinone

About the Company : Alven strengths lie in the development of highly complex molecules, technological leadership and efficiency in production. All our R&D work is driven by basic rule – the result o...

Alven strengths lie in the development of highly complex molecules, technological leadership and efficiency in production. All our R&D work is driven by basic rule – the result of the laboratory work leads to technologically suitable and highly efficient processes for commercial production. Ultimate emphasis on technological efficiency and optimised synthetic processes allow cost leadership combined with environmental sustainability.
blank

06

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

Nitisinone

About the Company : Danesh Kimia Pharmed Co. was established on 2011 by industrial and university researchers in order to invest on the production of new pharmaceutical molecules and their ready to us...

Danesh Kimia Pharmed Co. was established on 2011 by industrial and university researchers in order to invest on the production of new pharmaceutical molecules and their ready to use pharmaceutical dosage forms. The company is known as the pioneer generic producer for new entities and ready to use pharmaceutical formulations made by research and production units. It has created a production line for anticancer active ingredients in Baran Chemical and Pharmaceutical Co., molecules in low quantity with high value such as Fingolimod, Nitisinone, Bosentan, etc.
blank

07

Hetero Drugs

India
AES 2024
Not Confirmed
arrow

Hetero Drugs

India
arrow
AES 2024
Not Confirmed

Nitisinone

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

08

AES 2024
Not Confirmed
arrow
arrow
AES 2024
Not Confirmed

Nitisinone

About the Company : Established in the early 90’s SCL offers a wide range of Active Pharmaceutical Ingredients and Intermediates to its customers worldwide. SCL’s products are exported to Europe, ...

Established in the early 90’s SCL offers a wide range of Active Pharmaceutical Ingredients and Intermediates to its customers worldwide. SCL’s products are exported to Europe, Japan, Russia, South and Central America, ASEAN, W. Asia, MENA regions. SCL’s manufacturing facilities have been built to comply with EU GMP and U.S. FDA norms, and the API facility has been successfully certified as EU GMP compliant five times by the European Authorities. Latest certification was carried out by German Health Authority.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"NITISINONE","year":"2021","qtr":"Q1","strtotime":1609698600,"product":"NITISINONE ((OTHERS) (B.NO.NTN200003 M:0","address":"SCF.287, MOTOR MARKET,MANIMAJRA,","city":"CHANDIGARH.","supplier":"SAURAV CHEMICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"THE MANAGER ..","customerCountry":"ARGENTINA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"120000","totalValueFC":"3377.2","currency":"USD","unitRateINR":8233333.333333334,"date":"04-Jan-2021","totalValueINR":"247000","totalValueInUsd":"3377.2","indian_port":"DELHI AIR","hs_no":"29147990","bill_no":"7658750","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"SCF.287, MOTOR MARKET,MANIMAJRA,, CHANDIGARH.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658255400,"product":"NITISINONE (IN HOUSE) BATCH.NO.NTN200003","address":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA","city":"PANCHKULA,HARYANA","supplier":"SAURAV CHEMICALS","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"QUIBI S.A. PRODUCTOR Y SERVICIOS FA","customerCountry":"COLOMBIA","quantity":"0.17","actualQuantity":"0.17","unit":"KGS","unitRateFc":"120000","totalValueFC":"19907.8","currency":"USD","unitRateINR":9311764.7058823518,"date":"20-Jul-2022","totalValueINR":"1583000","totalValueInUsd":"19907.8","indian_port":"DELHI AIR","hs_no":"29147990","bill_no":"2934735","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA, PANCHKULA,HARYANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673893800,"product":"NITISINONE (IN-HOUSE)(OTHER VEG ALKALOID","address":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA","city":"PANCHKULA,HARYANA","supplier":"SAURAV CHEMICALS","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"TO THE ORDER OF","customerCountry":"UNITED KINGDOM","quantity":"0.04","actualQuantity":"0.04","unit":"KGS","unitRateFc":"120000","totalValueFC":"4806.8","currency":"USD","unitRateINR":9825000,"date":"17-Jan-2023","totalValueINR":"393000","totalValueInUsd":"4806.8","indian_port":"DELHI AIR","hs_no":"29147990","bill_no":"7035764","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA, PANCHKULA,HARYANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683570600,"product":"NITISINONE IN HOUSE OTHR VEG ALKALOIDSNTRL OR RPRDCD BY SYNTHS THR SALTS ESTRSETHERSAND OTHER DRVTVS","address":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA","city":"PANCHKULA,HARYANA","supplier":"SAURAV CHEMICALS","supplierCountry":"INDIA","foreign_port":"LONDON HEATHROW","customer":"TO THE ORDER","customerCountry":"UNITED KINGDOM","quantity":"0.16","actualQuantity":"0.16","unit":"KGS","unitRateFc":"120000","totalValueFC":"18849.3","currency":"USD","unitRateINR":9693750,"date":"09-May-2023","totalValueINR":"1551000","totalValueInUsd":"18849.3","indian_port":"DELHI AIR","hs_no":"29147990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA, PANCHKULA,HARYANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683657000,"product":"NITISINONE IN HOUSE OTHR VEG ALKALOIDSNTRL OR RPRDCD BY SYNTHS THR SALTS ESTRSETHERSAND OTHER DRVTVS","address":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA","city":"PANCHKULA,HARYANA","supplier":"SAURAV CHEMICALS","supplierCountry":"INDIA","foreign_port":"LONDON HEATHROW","customer":"TO THE ORDER","customerCountry":"UNITED KINGDOM","quantity":"0.16","actualQuantity":"0.16","unit":"KGS","unitRateFc":"120000","totalValueFC":"18849.3","currency":"USD","unitRateINR":9693750,"date":"10-May-2023","totalValueINR":"1551000","totalValueInUsd":"18849.3","indian_port":"DELHI AIR","hs_no":"29147990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"PLOT NO. 370. IND. AREA PHASE 2,PA NCHKULA, PANCHKULA,HARYANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699900200,"product":"NITISINONE (IN-HOUSE). BATCH NO.NTN200005,MFG.DATE.:01.02.2020,RE-TEST DATE.: 31.01.2024,","address":"SCF.287, MOTOR MARKET,","city":"CHANDIGARH.","supplier":"SAURAV CHEMICALS","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"TO THE ORDER OF","customerCountry":"UNITED KINGDOM","quantity":"0.08","actualQuantity":"0.08","unit":"KGS","unitRateFc":"120000","totalValueFC":"9487.1","currency":"USD","unitRateINR":9875000,"date":"14-Nov-2023","totalValueINR":"790000","totalValueInUsd":"9487.1","indian_port":"Delhi Air","hs_no":"29147990","bill_no":"5348154","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"SCF.287, MOTOR MARKET,, CHANDIGARH.","customerAddress":""}]
04-Jan-2021
14-Nov-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Nitisinone

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

02

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Nitisinone

Brand Name :

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

03

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Nitisinone

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

04

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

NITISINONE

Brand Name : NITISINONE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2023-05-25

Application Number : 216201

Regulatory Info : RX

Registration Country : USA

blank

05

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

NITISINONE

Brand Name : NITISINONE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2022-05-26

Application Number : 212390

Regulatory Info : RX

Registration Country : USA

blank

06

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

nitisinon

Brand Name : Orfadin

Dosage Form : ORAL SUSPENSION

Dosage Strength : 4 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Nitisinone

Brand Name : Orfadin

Dosage Form : Nitisinone 10Mg 60 Units Oral Use

Dosage Strength : 60 cps 10 mg vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Nitisinone

Brand Name : Orfadin

Dosage Form : Capsule, hard

Dosage Strength : 5 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Nitisinone

Brand Name : ORFADIN

Dosage Form : Hard Capsule For Oral Use

Dosage Strength : 5 mg

Packaging : 60 UNITS 5 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

NITISINONE

Brand Name : NITISINONE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2023-01-09

Application Number : 215908

Regulatory Info : DISCN

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Solubilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Empty Capsules

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Taste Masking

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Coloring Agents

read-more
read-more

Emulsifying Agents

read-more
read-more

Topical

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty